Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis

作者: G D Smith , B E Chadwick , C Willmore-Payne , J S Bentz

DOI: 10.1136/JCP.2007.051425

关键词:

摘要: Background: Activating epidermal growth factor receptor (EGFR) mutations have been implicated in non-small cell lung cancer (NSCLC), and also clinically correlated with patient sensitivity to targeted EGFR inhibitors. Aim: To describe a technique for determining mutation status on archival fine needle aspirate (FNA) specimens from advanced NSCLC patients. Methods: Eleven FNA slides patients were examined diagnostic material identify tumour cell-enriched regions. was determined using slide-scrape DNA extraction protocol of selected regions the smear slides, followed by real time PCR high resolution melt analysis (HRMAA) exons 18, 19, 20, 21, sequence analysis. Results: All samples successfully amplified PCR. Three adenocarcinoma contained exon 19 (L747-P753insS). One three had an additional (A755D). Conclusions: Archival cytology can be used determine PCR, HRMAA, sequencing. The ability use greatly increases potential available molecular diagnosis selection therapeutic agents.

参考文章(30)
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
Takayuki Kosaka, Yasushi Yatabe, Hideki Endoh, Kimihide Yoshida, Toyoaki Hida, Masahiro Tsuboi, Hirohito Tada, Hiroyuki Kuwano, Tetsuya Mitsudomi, Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib Clinical Cancer Research. ,vol. 12, pp. 5764- 5769 ,(2006) , 10.1158/1078-0432.CCR-06-0714
Ludmila Prudkin, Ignacio I. Wistuba, Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications Annals of Diagnostic Pathology. ,vol. 10, pp. 306- 315 ,(2006) , 10.1016/J.ANNDIAGPATH.2006.06.011
William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus, Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain PLoS Medicine. ,vol. 2, pp. e73- ,(2005) , 10.1371/JOURNAL.PMED.0020073
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balázs Halmos, EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib The New England Journal of Medicine. ,vol. 352, pp. 786- 792 ,(2005) , 10.1056/NEJMOA044238
Raffaella Sordella, Daphne W Bell, Daniel A Haber, Jeffrey Settleman, Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways Science. ,vol. 305, pp. 1163- 1167 ,(2004) , 10.1126/SCIENCE.1101637
Heidi Greulich, Tzu-Hsiu Chen, Whei Feng, Pasi A Jänne, James V Alvarez, Mauro Zappaterra, Sara E Bulmer, David A Frank, William C Hahn, William R Sellers, Matthew Meyerson, Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants PLoS Medicine. ,vol. 2, pp. e313- ,(2005) , 10.1371/JOURNAL.PMED.0020313
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Jung-Ta Chen, Michael A. Lane, Douglas P. Clark, Inhibitors of the polymerase chain reaction in Papanicolaou stain. Removal with a simple destaining procedure. Acta Cytologica. ,vol. 40, pp. 873- 877 ,(1996) , 10.1159/000333994
Jeffrey A Engelman, Toru Mukohara, Kreshnik Zejnullahu, Eugene Lifshits, Ana M Borrás, Christopher-Michael Gale, George N Naumov, Beow Y Yeap, Emily Jarrell, Jason Sun, Sean Tracy, Xiaojun Zhao, John V Heymach, Bruce E Johnson, Lewis C Cantley, Pasi A Jänne, None, Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer Journal of Clinical Investigation. ,vol. 116, pp. 2695- 2706 ,(2006) , 10.1172/JCI28656